TY - JOUR
T1 - Cognitive behavioral therapy for persons living with HIV in China
T2 - A randomized pilot trial
AU - Han, Shuyu
AU - Hu, Yan
AU - Lu, Hongzhou
AU - Zhang, Lin
AU - Zhu, Zheng
AU - Luo, Jianfeng
AU - Relf, Michael V.
AU - Mulawa, Marta I.
AU - Pei, Yaolin
AU - Wu, Bei
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Background: Chinese persons living with HIV (PLWH) suffer from prevalent mental health issues. We aimed to develop a tailored cognitive behavioral therapy (CBT), test its feasibility, acceptability, and preliminary effects (depression, anxiety, and medication adherence) for Chinese PLWH. Methods: Twenty PLWH were assigned randomly. Intervention participants learned skills in CBT and relaxation training in a tailored group-based weekly 10-session project. Each session lasted for two hours and was delivered by nurses and volunteers. Control participants only received laboratory tests and free antiretroviral therapy (ART) medication. Feasibility and acceptability were descriptively summarized. Depression, anxiety, and ART medication adherence data were collected at the baseline (T0), after the intervention (T1) and after 6 months of follow-up (T2). Results: The average CBT attendance rate for all sessions was 60%. No participants in the intervention group dropped out of the study. All participants in the intervention group agreed that they could benefit from the CBT. Participants in the intervention group showed a greater improvement in anxiety and self-reported ART medication adherence than those in the control group at T1. However, no preliminary intervention effect was found at T2. Limitations: The small sample size leads to a lack of representativeness in the study sample. We excluded participants with severe comorbidities, which may lead to an underestimate of the intervention effect of CBT among Chinese PLWH. Conclusions: CBT is feasible and acceptable, demonstrating promising preliminary effects on anxiety and ART medication adherence among Chinese PLWH. Additional research is needed to test the effectiveness of this approach.
AB - Background: Chinese persons living with HIV (PLWH) suffer from prevalent mental health issues. We aimed to develop a tailored cognitive behavioral therapy (CBT), test its feasibility, acceptability, and preliminary effects (depression, anxiety, and medication adherence) for Chinese PLWH. Methods: Twenty PLWH were assigned randomly. Intervention participants learned skills in CBT and relaxation training in a tailored group-based weekly 10-session project. Each session lasted for two hours and was delivered by nurses and volunteers. Control participants only received laboratory tests and free antiretroviral therapy (ART) medication. Feasibility and acceptability were descriptively summarized. Depression, anxiety, and ART medication adherence data were collected at the baseline (T0), after the intervention (T1) and after 6 months of follow-up (T2). Results: The average CBT attendance rate for all sessions was 60%. No participants in the intervention group dropped out of the study. All participants in the intervention group agreed that they could benefit from the CBT. Participants in the intervention group showed a greater improvement in anxiety and self-reported ART medication adherence than those in the control group at T1. However, no preliminary intervention effect was found at T2. Limitations: The small sample size leads to a lack of representativeness in the study sample. We excluded participants with severe comorbidities, which may lead to an underestimate of the intervention effect of CBT among Chinese PLWH. Conclusions: CBT is feasible and acceptable, demonstrating promising preliminary effects on anxiety and ART medication adherence among Chinese PLWH. Additional research is needed to test the effectiveness of this approach.
KW - AIDS
KW - Anxiety
KW - Cognitive Behavioral Therapy
KW - Depression
KW - HIV
KW - Medication Adherence
UR - http://www.scopus.com/inward/record.url?scp=85083012073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083012073&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2020.08.085
DO - 10.1016/j.jad.2020.08.085
M3 - Article
C2 - 32911214
AN - SCOPUS:85083012073
SN - 0165-0327
VL - 277
SP - 640
EP - 648
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -